Literature DB >> 8951484

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

A G Douglas-Jones1, S K Gupta, R L Attanoos, J M Morgan, R E Mansel.   

Abstract

The in-situ component of 180 cases of screen detected infiltrating duct carcinoma of the breast was classified according to six published classifications for ductal carcinoma in situ based on architecture, necrosis and cytology. All cases were assessed independently by two experienced observers to assess inter-observer variation. The differentiation of ductal carcinoma in situ as assessed by all the classification systems correlated with the grade of the associated invasive carcinoma (chi-squared between 50 and 107: P < 0.0001). Disagreements were commonest in the assessment of architecture and least common in the assessment of necrosis. For cytonuclear grade most disagreements (62.2%) involved the distinction between low and intermediate as against 33.9% disagreements for intermediate vs. high. Nuclear grade alone and necrosis alone were correlated with the grade of invasive carcinoma associated with the ductal carcinoma in situ and the Nottingham prognostic index of the patient. The Van Nuys classification of ductal carcinoma in situ is commended because it has a low inter-observer disagreement, is significantly correlated with the grade of the infiltrating carcinoma, uses simple well-defined criteria (with no requirement for percentage estimations), is applicable to small numbers of ducts and, most importantly, appears to correlate with disease-free survival.

Entities:  

Mesh:

Year:  1996        PMID: 8951484     DOI: 10.1046/j.1365-2559.1996.d01-513.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  23 in total

1.  Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.

Authors:  A G Douglas-Jones; J M Morgan; M A Appleton; R L Attanoos; A Caslin; C S Champ; M Cotter; N S Dallimore; A Dawson; R W Fortt; A P Griffiths; M Hughes; P A Kitching; C O'Brien; A M Rashid; D Stock; A Verghese; D W Williams; N W Williams; S Williams
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.

Authors:  A G Douglas-Jones; J Logan; J M Morgan; R Johnson; R Williams
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 3.  Ductal carcinoma in situ of the breast.

Authors:  M J Silverstein
Journal:  BMJ       Date:  1998-09-12

4.  E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast.

Authors:  S K Gupta; A G Douglas-Jones; B Jasani; J M Morgan; M Pignatelli; R E Mansel
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

5.  C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.

Authors:  Filiz Eren; Zerrin Calay; Haydar Durak; Bülent Eren; Nil Comunoğlu; Ovgü Aydin
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

6.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

7.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

8.  The diagnostic challenge of low-grade ductal carcinoma in situ.

Authors:  Tracy Onega; Donald L Weaver; Paul D Frederick; Kimberly H Allison; Anna N A Tosteson; Patricia A Carney; Berta M Geller; Gary M Longton; Heidi D Nelson; Natalia V Oster; Margaret S Pepe; Joann G Elmore
Journal:  Eur J Cancer       Date:  2017-05-20       Impact factor: 9.162

9.  Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast?

Authors:  Alfredo Ribeiro-Silva; Leandra N Zamzelli Ramalho; Sérgio Britto Garcia; Sérgio Zucoloto
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

10.  Heterogeneity of invasive ductal carcinoma: proposal for a hypothetical classification.

Authors:  Baik-Hyeon Jo; Yi-Kyeong Chun
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.